Basic symptoms in stable schizophrenia: Relations with functioning and quality of life

Clinical Neuropsychiatry

Volumn 7, Issue 3, 2010, Pages 100-110

  Rocca, Paola ^a   Pulvirenti, Laura ^a   Montemagni, Cristiana ^a   Rasetti, Roberta ^a   Rocca, Giuseppe ^a   Bogetto, Filippo ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Basic symptoms; FBF; GAF; Quality of life; Schizophrenia

Indexed keywords

ADULT; AGED; ARTICLE; DAILY LIFE ACTIVITY; FEMALE; FUNCTIONAL STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; OUTCOME ASSESSMENT; OUTPATIENT; PERSONAL EXPERIENCE; POSITIVE AND NEGATIVE SYNDROME SCALE; PREDICTOR VARIABLE; PSYCHOSIS; QUALITY OF LIFE; SCHIZOPHRENIA; SOCIAL INTERACTION; SYMPTOM;

EID: 77957739518     PISSN: 17244935     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (79)

1. American Psychiatric Association, APA (2000). Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR). American Psychiatric Press, Washington, DC.
2. Addington D, Addington J, Schissel B (1990). A depression rating scale for schizophrenics. Schizophrenia Research 3, 247-251.
3. Altshuler LL, Gitlin MJ, Mintz J, Leight JL, Frye MA (2002). Subsyndromal depression is associated with functional impairment in patients with bipolar disorder. Journal of Clinical Psychiatry 63, 807-811.
4. Andreasen NC (1983). The Scale for the Assessment of Negative Symptoms (SANS). Iowa City, University of Iowa.
5. Barry MM (1997). Well-being and life satisfaction as components of quality of life in mental disorders. In: Katschnig H, Freeman H, Sartorius N (Eds) Quality of Life in Mental Disorders. New York, NY, Wiley, 31-42.
6. Bromet EJ, Naz B, Fochtmann LJ, Carlson GA, Tanenberg-Karant M (2005). Long-term diagnostic stability and outcome in recent first-episode cohort studies of schizophrenia. Schizophrenia Bulletin 31, 639-649.
7. Burns T, Patrick D (2007). Social functioning as an outcome measure in schizophrenia studies. Acta Psychiatrica Scandinavica 116, 403-418.
8. Cuesta MJ, Peralta V, Irigoyen I (1996). Factor analysis of the Frankfurt Complaint Questionnaire in a Spanish sample. Psychopathology 29, 1, 46-53.
9. de Souza LA, Coutinho ES (2006). The quality of life of people with schizophrenia living in community in Rio de Janeiro, Brazil. Social Psychiatry and Psychiatric Epidemiology 41, 5, 347-356.
10. Eack SM, Newhill CE (2007). Psychiatric symptoms and quality of life in schizophrenia: a meta-analysis. Schizophrenia Bulletin 33, 5, 1225-1237.
11. First MB, Gibbon M, Spitzer RL, Williams JBW, Benjamin LS (1997). Structured Clinical Interview for DSM-IV Disorders (SCID). American Psychiatric Press, Washington DC.
12. Fitzgerald PB, Williams CL, Corteling N, Filia SL, Brewer K, Adams A.(2001). Subject and observer-rated quality of life in schizophrenia. Acta Psichiatrica Scandinavica 103, 387-392.
13. Grant P, Beck AT (2008). Defeatist beliefs as a mediator of cognitive impairment, negative symptoms, and functioning in schizophrenia. Schizophrenia Bulletin Feb 27. [Epub ahead of print].
14. Green MF (1996). What are the functional consequences of neurocognitive deficits in schizophrenia? American Journal of Psychiatry 153, 321-330.
15. Green MF, Kern RS, Braff DL, Mintz J (2000). Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff''? Schizophrenia Research 26, 119-136.
16. Gross G (1989). The "basic" symptoms of schizophrenia. British Journal of2Psychiatry Supplementum 7, 21-25.
17. Gross G (1997). The onset of schizophrenia. Schizophrenia Research 28, 2-3, 187-198.
18. Harvey PD, Green MF, Keefe RSE, Velligan DI (2004). Cognitive functioning in schizophrenia: a consensus statement on its role in the definition and evaluation of effective treatments for the illness. Journal of Clinical Psychiatry 65, 361-372.
19. Heinrichs DW, Hanlon TE, Carpenter WT Jr (1984). The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. Schizophrenia Bulletin 10, 3, 388-398.
20. Hirsch SR, Jolley AG, Barnes TR, Liddle PF, Curson DA, Patel A, York A, Bercu S, Patel M (1989). Dysphoric and depressive symptoms in chronic schizophrenia. Schizophrenia Research 2, 3, 259-264.
21. Hofer A, Baumgartner S, Bodner T, Edlinger M, Hummer M, Kemmler G (2005). Patient outcomes in schizophrenia II: the impact of cognition. European Psychiatry 20, 395-402.
22. Huber G (1957). Die coenesthetische schizophrenie. Fortschritte fur Neurologie undPsychiatrie 25, 491-520.
23. Huber G, Gross G, Schuttler R (1979). Schizophrenie. Eine verlaufs- und sozialpsychiatrische Langzeitstudie. Berlin, Springer.
24. Huber G (1983). The concept of substrate-close basic symptoms and its significance for the theory and therapy of schizophrenic diseases. Nervenarzt 54, 1, 23-32.
25. Huber G, Gross G (1989). The concept of basic symptoms in schizophrenic and schizoaffective psychoses. Recenti Prog Med 80, 12, 646-652.
26. Huber G, Gross G (1995). The concept of basic symptoms and basic stages and its meaning for schizophrenia and schizoaffective psychoses. In C. Maggini (ed) Psicopatologia e clinica della Schizofrenia. ETS, Pisa, Italy, 41-58.
27. Jaeger J, Bitter I, Czobor P, Volavka J (1990). The measurement of subjective experience in schizophrenia: the Subjective Deficit Syndrome Scale. Comprehensive Psychiatry 31, 3, 216-226.
28. Jones SH, Thornicroft G, Coffey M, Dunn G (1995). A brief mental health outcome scale-reliability and validity of the Global Assessment of Functioning (GAF). British Journal of Psychiatry 166, 654-659.
29. Kaiser W, Priebe S (1998). Measuring changes in subjective quality of life in chronic schizophrenic patients. Nervenarzt 69, 3, 219-227.
30. Kay SR, Fiszbein A, Opler LA (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13, 2, 261-276.
31. Klosterkötter J (1988). Basissymptome und endphanomene der schizophrenie. Springer, Berlin.
32. Klosterkötter J. (1992). The meaning of basic symptoms for the genesis of the schizophrenic nuclear syndrome. Jpn Journal of2Psychiatry Neurology 46, 3, 609-30.
33. Klosterkötter J, Ebel H, Schultze-Lutter F, Steinmeyer EM (1996). Diagnostic validity of basic symptoms. European Archives of Psychiatry and Clinical Neuroscience 246, 3, 147-154.
34. Klosterkötter J, Schultze-Lutter F, Gross G, Huber G, Steinmeyer EM (1997). Early self-experienced neuropsychological deficits and subsequent schizophrenic diseases: an 8-year average follow-up prospective study. Acta Psychiatrica Scandinavica 95, 5, 396-404.
35. Kusel Y, Laugharne R, Perrington S, McKendrick J, Stephenson D, Stockton Henderson J.(2007). Measurement of quality of life in schizophrenia: a comparison of two scales. Social Psychiatry and Psychiatric Epidemiology 2007 42, 10, 819-823.
36. Lambert M, Naber D (2004). Current issues in schizophrenia: overview of patient acceptability, functioning capacity and quality of life. CNS Drugs 18, 2, 5-17.
37. Liddle PF, Barnes TR (1988). The subjective experience of deficits in schizophrenia. Comprehensive Psychiatry 29, 2, 157-164.
38. Liddle PF, Barnes TR, Curson DA, Patel M. (1993). Depression and the experience of psychological deficits in schizophrenia. Acta Psychiatrica Scandinavica 88, 4, 243-247.
39. Loas G, Yon V, Brien D (2002). Dimensional structure od the Frankfurt Complaint Questionnaire. Comprehensive Psychiatry 43, 5, 397-403.
40. Maggini C, Raballo A (2006). Exploring depression in schizophrenia. European Psychiatry 21, 4, 227-232.
41. Malla AK, Norman RM, McLean TS, McIntosh E (2001). Impact of phase-specific treatment of first episode of psychosis on Wisconsin Quality of Life Index (client version). Acta Psychiatrica Scandinavica 103, 5, 355-361.
42. Martinez-Arán A, Vieta E, Colom F, Torrent C, Sánchez-Moreno J, Reinares M, Benabarré A, Goikolea JM, Brugue E, Daban C, Salamero M (2004). Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome. Bipolar Disorder 6, 224-232.
43. Martinez-Aran A, Vieta E, Torrent C, Sanchez-Moreno J, Goikolea JM, Salamero M, Malhi GS, Gonzalez-Pinto A, Daban C, Alvarez-Grandi S, Fountoulakis K, Kaprinis G, Tabares-Seisdedos R, Ayuso-Mateos JL (2007). Functional outcome in bipolar disorder: the role of clinical and cognitive factors. Bipolar Disorder 9, 103-113.
44. Mass R, Haasen C, Krausz M (1997). Dimensional structure and diagnostic specificity of the Frankfurt Complaint Questionnaire. European Psychiatry 12, 3, 117-123.
45. Mass R, Weigel S, Schneider S, Klepsch R (1998). Schizophrenia-specific basic symptoms. A successful replication. Psychopathology 31, 3, 113-119.
46. Mass R, Schoemig T, Hitschfeld K, Wall E, Haasen C (2000). Psychopathological syndromes of schizophrenia: evaluation of the dimensional structure of the positive and negative syndrome scale. Schizophrenia Bulletin 26, 1, 167-177.
47. McGurk SR, Meltzer HY (2000a). The role of cognition in vocational functioning in schizophrenia. Schizophrenia Research 45, 175-184.
48. McGurk SR, Moriarty PJ, Harvey PD (2000b). Relationship of cognitive functioning, adaptive life skills, and negative symptoms severity in poor-outcome geriatric schizophrenia patients. Journal of Neuropsychopharmacology and Clinical Neuroscience 12, 257-264.
49. Milev P, Ho B, Arndt S, Andreasen NC (2005). Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. American Journal of Psychiatry 162, 495-506.
50. Nakaya M, Kusumoto K, Ohmori K (2002). Subjective experiences of Japanese inpatients with chronic schizophrenia. Journal of2Nervous and Mental Disorders 190, 2, 80-85.
51. Narvaez JM, Twamley EW, McKibbin CL, Heaton RK, Patterson TL (2008). Subjective and objective quality of life in schizophrenia. Schizophrenia Research 98, 1-3, 201-208.
52. Nelson B, Yung AR, Bechdolf A, McGorry PD (2008). The phenomenological critique and self-disturbance: implications for ultra-high risk ("prodrome") research. Schizophrenia Bulletin 34, 2, 381-392.
53. Norman RM, Malla AK, McLean T, Voruganti LP, Cortese L, McIntosh E (2000). The relationship of symptoms and level of functioning in schizophrenia to general wellbeing and the Quality of Life Scale. Acta Psychiatrica Scandinavica 102, 303-309.
54. Pallanti S, Quercioli L, Pazzagli A. (1997). Relapse in young paranoid schizophrenic patients: a prospective study of stressful life events, P300 measures, and coping. American Journal of Psychiatry 154, 6, 792-798.
55. Pallanti S, Quercioli L, Pazzagli A (1999). Basic symptoms and P300 abnormalities in young schizophrenic patients. Comprehensive Psychiatry 40, 5, 363-371.
56. Peralta V, Cuesta MJ, de Leon J (1992). Positive versus negative schizophrenia and basic symptoms. Comprehensive Psychiatry 33, 3, 202-206.
57. Perlick DA, Perlick DA, Rosenheck RA, Kaczynski R, Bingham S, Collins J (2008). Association of symptomatology and cognitive deficits to functional capacity in schizophrenia. Schizophrenia Research 99, 1-3, 192-199.
58. Priebe S (2007). Social outcomes in schizophrenia. British Journal of Psychiatry Supplementum 50, 15-20.
59. Rey ER (1982). Identifizierung und Verlauf kognitiver Storungen Schizophrener. Arbeitsbericht des Sonderforschungsbe-reiches 116 (Psychiatrische Epidemiologie), Zentralinstitut fur Seelische Gesundheit, Fribourg, 139-290.
60. Ritsner M, Kurs R, Gibel A, Ratner Y, Endicott J (2005). Validity of an abbreviated quality of life enjoyment and satisfaction questionnaire (Q-LES-Q-18) for schizophrenia, schizoaffective, and mood disorder patients. Quality of 2 Life Research 14, 7, 1693-1703.
61. Ritsner M, Gibel A, Ratner Y (2006). Determinants of changes in perceived quality of life in the course of schizophrenia. Quality of Life Research 15, 3, 515-526.
62. Rocca P, Bellino S, Calvarese P, Marchiaro L, Patria L, Rasetti R (2005). Depressive and negative symptoms in schizophrenia: different effects on clinical features. Comprehensive Psychiatry 46, 304-310.
63. Rocca P, Giugiario M, Montemagni C, Rigazzi C, Rocca G, Bogetto F (2009). Quality of life and psychopathology during the course of schizophrenia. Comprehensive Psychiatry 50, 6, 542-548.
64. Rosler M, Bellaire W, Hengesch G, Kiesling-Muck H, Carls W (1985). Die uncharakteristischen Basissymptome des Frankfurter-Beschwerdefragebogens und ihre Beziehungen zu psychopathologischen Syndromen. Nervenarzt 56, 259-264.
65. Sass LA, Parnas J (2003). Schizophrenia, consciousness, and the self. Schizophrenia Bulletin 29, 3, 427-44.
66. Schultze-Lutter F (2009). Subjective symptoms of schizophrenia in research and the clinic: the basic symptoms concept. Schizophrenia Bullettin 35, 1, 5-8.
67. Schunemann-Wurmthaler S (1984). Subjektive Basisstorungen der Schizophrenic: Die Standardisierung ihrer Erhebung und ihre Einordnung in den Rahmen schizophrener Symptomatik. Lang, Stuttgart.
68. Sim K, Mahendran R, Siris SG, Heckers S, Chong SA (2004). Subjective quality of life in first episode schizophrenia spectrum disorders with comorbid depression. Psychiatry Research 129, 2, 141-147.
69. Spaulding WD, Storms L, Goodrich V, Sullivan M (1986). Application of experimental psychopathology in psychiatric rehabilitation. Schizophrenia Bulletin 12, 4, 560-577.
70. Stanghellini G, Quercioli L, Ricca V, Strik WK, Cabras P (1991). Basic symptoms and negative symptoms in the light of language impairment. Comprehensive Psychiatry 32, 2, 141-146.
71. Sullwold L (1986). Frankfurter Beschwerde Fragebogen. In Sullwold L, Huber G, Schizophrene Bassistorungen. Springer, Berlin, Germany, 145-159.
72. Uhlhaas PJ, Mishara AL (2007). Perceptual anomalies in schizophrenia: integrating phenomenology and cognitive neuroscience. Schizophrenia Bulletin 33, 1, 142-156.
73. Velligan DI, Bow-Thomas CC, Mahurin RK, Miller AL, Halgunseth LC (2000). Do specific neurocognitive deficits predict specific domains of community function in schizophrenia? Journal of Nervous and Mental Disorder 188, 518-524.
74. Wegener S, Redoblado-Hodge MA, Lucas S, Fitzgerald D, Harris A, Brennan J (2005). Relative contributions of psychiatric symptoms and neuropsychological functioning to quality of life in first-episode psychosis. Australian and New Zealand Journal of Psychiatry 39, 6, 487-492.
75. Wittorf A, Wiedemann G, Buchkremer G, Klingberg S. (2008). Prediction of community outcome in schizophrenia 1 year after discharge from inpatient treatment. European Archives of Psychiatry and Clinical Neuroscience 258, 48-58.
76. Woods SW (2003). Chlorpromazine equivalent doses for the newer atypical antipsychotics. Journal of Clinical Psychiatry 64, 663-667.
77. Yon V, Loas G (2000). Relationships between subjective experiences of deficit and other psychopathological features in schizophrenia. Psychopathology 33, 3, 110-114.
78. Yon V, Loas G, Brien D (2005). Subjective experiences and the psychopathological dimensions in schizophrenia. Psychiatry Research 137, 1-2, 93-102.
79. Yon V, Loas G, Monestes JL (2008). Dimensional structure of the Frankfurt Complaint Questionnaire in a sample of French students. Psychopathology 41, 2, 85-89.